Elicio Therapeutics
We harness the natural power of the lymph nodes to generate enhanced immune responses against tumors. Our science is defining the future of immunotherapy, with the goal of giving patients who are battling cancer their best possible outcome. We’re committed to engineering lymph node–targeted immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. We are an exceptional team of leaders dedicated to creating profound and enduring change in immuno-oncology. With expertise in materials science, immunology, and oncology, we plan to forge a new path forward for cancer treatment by utilizing such expertise to drive our mission to amplify the potential of immunotherapies, empowering patients to fight cancer with full force.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
Who We Are
Angion is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address fibrotic diseases and acute organ injuries.
The Angion team is dedicated to bring new therapeutic options to patients. Currently our primary focus is chronic fibrotic conditions in the lung and kidney where effective treatments with more limited off-target toxicities are needed.